Technology | 2007.07.12
George Mason University's CAP-CLIA Laboratory Utilizes Aushon BioSystems' Array Technology for Individualized and Targeted Treatment for Cancer Patients
BURLINGTON, Mass.--(BUSINESS WIRE)--In a cooperative effort to promote the development of personalized medicine based on reverse-phase protein array technology, Aushon BioSystems has placed
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=
